Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Clinical trial NCT06959511 · RECRUITING

Trial details

NCT number: NCT06959511
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoadjuvant Treatment Thyroid Cancer

Start date: 2025-07-22
Primary completion: 2028-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.